Neurology

A cup of coffee/day keeps migraine away? It can, but before recommending another cup to migraine patients, review findings just published.

Caffeine moderation moderates cardiovascular risk, caffeine is not what is keeping you up at night, and 4 more recent studies on caffeine intake. 

When treating patients with chronic headache or migraine, assessing sleep quality can be critical, according to this specialist. 

Here: A snapshot of the 4 FDA-approved neuromodulation devices and a primer on neuromodulation for migraine at work.

Neuromodulation to treat migraine and other primary headaches is proven effective in clinical trials and may be an option for your patients looking for drug-free relief.

Mindfulness, an attention-control technique, can augment medical therapy for migraineurs, with stress reduction, relaxation, and shifting negative self judgement.

Headache diagnosis can be "a pain" all year 'round, but particularly irksome when you have summer plans. Neurologist Peter McAllister, MD, serves up some apps to help with that.

Headache specialist, Stephanie Nahas, MD, MSEd, discusses the importance of a migraine journal for both patient and physician. 

Identifying the unique symptoms and risk factors for stroke in women is key to providing effective care. Answer these 5 questions to see how much you know.

How can you help migraine patients who suffer from psychiatric conditions such as depression or anxiety? A headache expert says a simple question can make a huge impact. 

How do you help patients with migraine who ask for methods other than, or as adjuvants to, medical therapy? A headache expert offers suggestions to pass on.

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

A family physician with expertise in headache treatment makes the case for appropriate use of opioids in some patients.

Vestibular migraine may be a relatively new diagnostic entity, but a new study shows it impacts around 6 million US adults. 

Primary care clinicians may be the first to note an abnormal headache pattern that calls for referral. What do you know about these not-so-simple headaches?

Noninvasive vagus nerve stimulation may be a viable method for the treatment of acute episodic migraine, according to a new study.

The first CGRP mAb has been FDA-approved, but why should you consider this novel category for migraine prevention? 

Take a closer look at how erenumab, the first CGRP inhibitor to win FDA-approval for migraine prevention, earned that spot.

Menstrual migraine can be a tricky diagnosis. Test your knowledge of the headaches and gather clinical tips with our 8-question quiz.

How much do you know about migraine/severe headache in the US? Take our 10-question quiz to find out. 

Results from a recent analysis of trends in US migraine prevalence show disease burden higher in populations that may be neglected. Are any of your patients at risk? 

Drugs that treat migraine come from a variety of classes and reflect on- and off-label use. How current are you?

In the largest study to date of blockade of the greater occipital nerve for migraine treatment, more than half of patients claimed a 50% reduction in pain. 

Neurostimulators are an emerging treatment option for migraine patients who want non-pharmacologic treatment. Find out what you know about the three devices approved for use in the US.

One of my migraine patients taught me that I need to ask the very hard questions if I want to offer the best possible care.